Podchaser Logo
Home
Armchair Healthcare

Maxim Jacobs, Nathaniel Calloway

Armchair Healthcare

Good podcast? Give it some love!
Armchair Healthcare

Maxim Jacobs, Nathaniel Calloway

Armchair Healthcare

Episodes
Armchair Healthcare

Maxim Jacobs, Nathaniel Calloway

Armchair Healthcare

Good podcast? Give it some love!
Rate Podcast

Episodes of Armchair Healthcare

Mark All
Search Episodes...
In which our heroes discuss the impending doom coming from Wuhan. Also wtf FDA re SRPT?00:40 - We survived JPM!05:00 - Are we all going to die form Coronavirus?22:43 - The Goop series on Netflix26:22 - Amarin has the one oil to rule them al
In which we welcome our new commentator Wiktoria, and discuss the new BIIB shuck and jive.
Discuss the recent Relmada data, Geovax, Amyris, WeWork and more:01:15: RLMD data in TRD13:23 The GOVX disaster18:52 WeWork is being flushed down the toilet24:08 Will HR3 passage actually mean fewer drugs will be developed?29:49 Don't
People need some perspective on vaping and these opioid lawsuit liabilities are out of control and will hurt patients. Here is a table of contents:1:08 The hysteria around vaping14:44 A new penile traction device for Peyronie's16:38 Does
Novartis gives the FDA a headache, the FDA then gives Amarin a headache and people are trying to cure their problems with bleach.00:42 Novartis cheated18:47 There are two FDA's, one for AMRN and another for everyone else30:00 Don't drink bl
We discuss Auris Medical’s development programs for intranasal betahistine for acute vertigo as well as to treat some of the major side effects of antipsychotic medication.01:07 Auris’s AM-125 program for acute vertigo16:57 The Phase II trial
We discuss Carmat's total artificial heart, the technology, approval pathways and commercial potential00:42 Carmat’s total artificial heart, the history and the technology08:54 The data so far18:00 The coming technological advances20:49
Why would anyone sign up for a vomit boat trial or get thousands of electrodes implanted into their brains?00:41 The VNDA vomit boat trial09:14 More on the KPTI approval11:52 Elon Musk's Neuralink18:44 Netflix has peaked
We cover Photocure’s marketed bladder cancer diagnostic product Hexvix/Cysview, its data and potential for growth in the United States and the prospects for future competition.01:03 – What does Photocure do?13:49 – How do the US and EU market
Why did selinexor get approved? What's going on with Roche/Spark? Why did ITCI have crazy results? Also a farewell.00:37 Michael Becker RIP02:22 What's up with the $KPTI approval14:19 Some confusing $ITCI data23:21 Why is the FTC takin
Also ABBV buys a company, and why academia sucks.00:30 - Vyleesi is the worst drug ever approved23:27 - Abbvie buys Allergan32:30 - Twitter censors tesladeaths.com34:14 - CRISPR babies in Russia?37:39 - Nat has a theory40:47 - The cabal r
Can anyone really beat diet and exercise for NASH? Also, buyer beware. Here is some more detail on what we talk about:00:39 Cymabay's disastrous NASH data, you're really better off with diet and exercise17:25 Ampion screws some investors
00:37 KRAS a hit at ASCO08:59 Enbrel for Alzheimer's?20:49 You don't need to take 10,000 steps a day24:58 Satanic messages from Google Translate27:30 What is up with the ARK model on TSLA?31:07 Gamestop has a really bad quarter35:09
An interview of Yuval Cohen, CEO of Corbus Pharmaceuticals where we discuss the cannabinoid space as well as the Corbus pipeline
Another what's wrong with people sort of episode:01:00 CYTK fails in Phase II but moves forward anyway06:40 OVID insults analysts18:42 Figging. Why?24:05 MNK bribes doctors28:35 TSLA and Peloton
Also we bid farewell to Briana.02:05 Was the MBRX pump on purpose?06:17 TSLA lost 4 board members on Good Friday12:52 AMRS was in default for a day, also announced on Good Friday17:00 Macro/financial system stuff27:22 The IQVIA report
Also the trajectory of GILD and eyes full of bees.00:43 Refusal to file letter for ZGNX14:30 Weirdness with AMRS27:00 Chinese scientists give human intelligence genes to monkeys34:48 Bees living off of a woman's tears36:48 GILD has layo
On the Sisyphean struggle that is the amyloid hypothesis. Also, space herpes.00:28 Biogen blows up21:00 Should Biogen buy Sage?33:10 Another nutritional cohort study42:55 Space herpes (watch out Elon Musk)
In which our heroes discuss Scott Gottlieb leaving, the new Theranos movie, and the risks of cutting sugar loaf.01:02 Scott Gottlieb is leaving the FDA10:35 The Inventor documentary on Theranos18:00 College bribery admissions scandal27:4
In which our heroes discuss Roche's motivations with Spark. Also musings on senate subcommittees and goat wine.00:43 Spark gets bought04:40 Senate drug pricing hearing16:22 The ER is an interesting place24:13 Karyopharm's panel29:19 B
Another NASH drug disappoints and three biotechs declare bankruptcy:00:35 Intercept's NASH drug has some questionable data15:45 Immune Pharma, Aradigm and Pernix declare bankruptcy24:10 Ambrosia gets a warning from the FDA35:15 Why woul
GILD messes up in NASH while OMER cult members buy a bill of goods.00:55 GILD fails in NASH, badly11:54 Who is OMER kidding?17:41 A Harvard geneticist claims to have found a Fountain of Youth supplement21:21 Brain buzzing headphones for los
Solid slips and Pain Therapeutics loses it. Also light bulbs for your ears and why Nat hates doctors:01:00 SLDB not so solid02:56 PTIE attacks FDA08:50 VNDA goes PETA11:56 Nat hates doctors16:33 Shining a light into ears to treat jet lag2
Here is what we talk about:00:30 Baby, it's cold outside04:15 BIIB Fight Club: they won't talk about interim analyses06:31 TYME debacle09:57 A cure for all cancers?14:08 Selling "young" blood16:30 An Alzheimer's vaccine company sta
You can jump out of a plane without a parachute but don’t use tap water with your neti pot:00:46 A study shows that parachutes do not lower mortality when jumping out of a plane06:27 Swans belong to the Queen14:30 NWBO > SGYP20:30 Lanne
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features